InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Neuraxis, INC

NRXS Clue Score52
United States Fiscal year ends December CIK 0001933567
$6.93 +2.36% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.93 +92.50% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 Aug 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue2.7Operating income−3.4Net income−4.8EPS, diluted−2.77Fiscal year 2023Revenue2.5 −8.4%Operating income−6.7Net income−14.6EPS, diluted−4.50Fiscal year 2024Revenue2.7 +9.2%Operating income−7.2Net income−8.2EPS, diluted−1.22Fiscal year 2025Revenue3.6 +32.9%Operating income−7.8Net income−7.8EPS, diluted−0.95
FY2022FY2023FY2024FY2025
Revenue 2.7 2.5 2.7 3.6
Growth −8.4% +9.2% +32.9%
Operating income −3.4 −6.7 −7.2 −7.8
Net income −4.8 −14.6 −8.2 −7.8
Growth
EPS, diluted −2.77 −4.50 −1.22 −0.95

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin88.9%Operating margin−125.6%Net margin−178.0%Free cash flow margin−85.6%Fiscal year 2023Gross margin87.7%Operating margin−270.9%Net margin−594.6%Free cash flow margin−273.4%Fiscal year 2024Gross margin86.5%Operating margin−266.5%Net margin−306.8%Free cash flow margin−228.1%Fiscal year 2025Gross margin84.2%Operating margin−219.4%Net margin−218.5%Free cash flow margin−181.1%
FY2022FY2023FY2024FY2025
Gross margin 88.9% 87.7% 86.5% 84.2%
Operating margin −125.6% −270.9% −266.5% −219.4%
Net margin −178.0% −594.6% −306.8% −218.5%
Free cash flow margin −85.6% −273.4% −228.1% −181.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−2.3Capital expenditure−0.0Free cash flow−2.3Fiscal year 2023Operating cash flow−6.7Capital expenditure−0.0Free cash flow−6.7Fiscal year 2024Operating cash flow−6.1Capital expenditure−0.0Free cash flow−6.1Fiscal year 2025Operating cash flow−6.4Capital expenditure−0.0Free cash flow−6.5
FY2022FY2023FY2024FY2025
Operating cash flow −2.3 −6.7 −6.1 −6.4
Capital expenditure −0.0 −0.0 −0.0 −0.0
Free cash flow −2.3 −6.7 −6.1 −6.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Cash0.3Total debt0.2Net cash (debt)0.0Shareholders’ equity−5.6Fiscal year 2023Cash0.1Shareholders’ equity−1.4Fiscal year 2024Cash3.7Shareholders’ equity2.1Fiscal year 2025Cash5.0Shareholders’ equity3.4
FY2022FY2023FY2024FY2025
Cash 0.3 0.1 3.7 5.0
Total debt 0.2 n/a n/a n/a
Net cash (debt) 0.0 n/a n/a n/a
Shareholders’ equity −5.6 −1.4 2.1 3.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
2.7 2.5 2.7 3.6
Growth −8.4% +9.2% +32.9%
0.3 0.3 0.4 0.6
2.4 2.2 2.3 3.0
Growth −9.7% +7.8% +29.4%
0.2 0.2 0.4 0.5
5.1 8.3 7.6 8.1
−3.4 −6.7 −7.2 −7.8
Growth
−4.8 −14.6 −8.2 −7.8
Growth
Per share
−2.77 −4.50 −1.22 −0.95
−2.77 −4.50 −1.22 −0.95
Growth
2.0 3.3 6.9 9.1
2.0 3.3 6.9 9.1
Growth +62.3% +112.7% +31.3%

† The diluted share count jumps at 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.